EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial

Ramón A Castaño, Maria A Granados, Natalia Trujillo, Juan P Bernal, Juan F Trujillo, Patrizia Trasmondi, Angel F Maestre, Juan S Cardona, Rossmary Gonzalez, María A Larrarte, Derly C Hernandez, Noël C Barengo und 1 weitere

Primary Care Diabetes · 2024

DOI: 10.1016/j.pcd.2024.09.005 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Primary Care Diabetes, 2024. Verfasst von Ramón A Castaño und 12 weiteren Autor:innen. Beteiligte Einrichtung: [UEB] Universidad El Bosque, Faculty of Medicine, Bogotá. Colombia. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Diabetes Mellitus, Type 2, Point-of-Care Testing, Glucose Tolerance Test. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Sanofi US.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Early detection of type 2 diabetes mellitus is key to reducing micro and macrovascular complications associated with this disease. However, a lab-based process for diagnosis entails the risk of loss-to-follow-up. The objective of this study was to demonstrate if performing a point-of-care test of HbA1c immediately after a screening questionnaire will increase the proportion of individuals showing up for a lab-based confirmatory test as Point-of-care (POC) provides immediate availability, which is expected to reduce loss-to-follow-up. RESEARCH DESIGN AND METHODS: This trial was a two-arm, randomized controlled, open-label study. Participants were recruited using the FINDRISC Score in a primary care and community setting. All 902 eligible participants were randomized into the intervention (n=511) and control (n=391) group. The intervention group was given information on healthy lifestyles, and a Point-of-care POC-HbA1c test was performed during the same visit. The control group was only given information on healthy lifestyles. Participants in both groups received a written prescription to have an oral glucose tolerance test (OGTT) performed within the next 30 days. Follow-up phone calls were made at 30 and 90 days to check if participant had undergone the test. The total duration of the intervention was 8 months. The posterior data analysis was made by using the Kolmogorov-Smirnoff test for the quantitative variables, and the descriptive statistics were expressed as means and standard deviation, or median and interquartile range 25 %-75 %, as appropriate. RESULTS: At 30 days, 28 % of participants in the intervention group and 26.1 % in the control group undertook the OGTT (RD 1.90 %; 95 % CI -3.94; 7.73). At 90 days, 35.8 % of participants in the intervention group and 37.1 % in the control group undertook the OGTT. There was no statistically significant difference (RD - 3.17 %; 95 % CI -7.04; 0.70) between both groups. CONCLUSIONS: The data suggest that performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinDiabetes Mellitus, Type 2Point-of-Care TestingGlucose Tolerance TestBiomarkersPredictive Value of TestsBlood GlucoseHumansFemaleMaleMiddle AgedRisk FactorsAgedTime FactorsAdultRisk AssessmentHealthy LifestyleEarly DiagnosisSurveys and QuestionnairesPatient Education as TopicPoint-of-Care Systems

Stichwörter der Autor:innen

DiabetesDiabetes MellitusGlycosylated Hemoglobin MeasurementHbAIc

Substanzen

Glycated Hemoglobinhemoglobin A1c protein, humanBiomarkersBlood Glucose

Autor:innen und Institutionen

  • [UEB] Universidad El Bosque, Faculty of Medicine, Bogotá. Colombia.
  • [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia.
  • [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia. Electronic address: angelmaestree@gmail.com.
  • [HWCM] Department of Medical Education, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA; [UNMdP] Escuela Superior de Medicina, Universidad Nacional de Mar del Plata, Mar del Plata,…

Förderung

  • Sanofi US

Zitieren

APA

Castaño, R. A., Granados, M. A., Trujillo, N., Bernal, J. P., Trujillo, J. F., Trasmondi, P., Maestre, A. F., Cardona, J. S., Gonzalez, R., Larrarte, M. A., Hernandez, D. C., Barengo, N. C., & Reynales, H. (2024). Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2024.09.005

Vancouver

Castaño RA, Granados MA, Trujillo N, Bernal JP, Trujillo JF, Trasmondi P, et al. Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial. Primary Care Diabetes. 2024. doi:10.1016/j.pcd.2024.09.005

BibTeX
@article{Castao2024,
  author = {Castaño, Ramón A and Granados, Maria A and Trujillo, Natalia and Bernal, Juan P and Trujillo, Juan F and Trasmondi, Patrizia and Maestre, Angel F and Cardona, Juan S and Gonzalez, Rossmary and Larrarte, María A and Hernandez, Derly C and Barengo, Noël C and Reynales, Humberto},
  title = {Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial},
  journal = {Primary Care Diabetes},
  year = {2024},
  doi = {10.1016/j.pcd.2024.09.005}
}
Kostenlos starten →